| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2878590 | The Annals of Thoracic Surgery | 2009 | 8 Pages |
Abstract
Prophylactic AVR for mild AS at CABG does not confer a survival benefit, and the likelihood of requiring AVR after CABG alone is low in the first 5 years. The decision to intervene on the valve is critically dependent upon the incremental operative risk imposed by concomitant AVR and late survival.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Basar MD, Thoralf M. MD, Hartzell V. MD, Maurice MD, Kevin L. MD, Rakesh M. MD, DPhil (Oxon), Harold M. MD, Soon J. MD, Joseph A. MD, Richard C. MD, Thomas A. MD,